N = 215 (152 adults, 63 children)a | Univariable analyses | Multivariable analyses | ||
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | P value | ||
Increasing age (by 10Y range) | All | 1.0 (0.9;1.1) | 1.0 (0.9;1.2) | 0.558 |
Adults | 1.6 (1.3;2.1) | 1.4 (1.0;1.8) | 0.027 | |
Children | 0.6 (0.2;1.8) | – | – | |
Bacterial co-infection | All | 1.6 (0.8;3.4) | 1.5 (0.7;3.3) | 0.340 |
Adults | 2.2 (0.9;5.2) | 1.7 (0.6;4.5) | 0.286 | |
Children | 0.8 (0.2;3.3) | 1.0 (0.2;4.6) | 0.995 | |
ALC | All | 1.0 (1.0;1.2) | 1.0 (1.0;1.2) | 0.420 |
Adults | 1.0 (1.0;1.2) | 1.0 (1.0;1.2) | 0.436 | |
Children | 0.8 (0.5;1.2) | 0.8 (0.5;1.2) | 0.309 | |
SOT | All | 2.1 (0.9;5.1) | 1.9 (0.8;4.6) | 0.166 |
Adults | 2.1 (0.9;5.4) | 1.6 (0.6;4.4) | 0.312 | |
Children | 1.7 (0.1;53.3) | – | – | |
Leukemia/lymphoma | All | 4.0 (1.7;9.5) | 3.9 (1.7;9.7) | 0.002 |
Adults | 3.0 (1.0;9.3) | 1.5 (0.4;5.2) | 0.556 | |
Children | 7.5(1.1;149.7) | – | – | |
Solid tumor | All | 7.2 (2.6;21.2) | 7.4 (2.7;21.9) | < 0.001 |
Adults | 7.4 (2.1;28.4) | 5.2 (1.4;20.9) | 0.015 | |
Children | 10.5 (1.2;240.1) | – | – | |
Chronic immunosuppressive medication | All | 10.5 (3.7;32.9) | 9.5 (3.3;30.2) | < 0.001 |
Adults | 8.2 (2.6;28.4) | 4.1 (1.1;16.0) | 0.034 | |
Children | 35.0 (2.6;1450.5) | – | – | |
PID | All | 4.3 (0.7–26.1) | 4.5 (0.7;29.0) | 0.097 |
Children | 10.5 (0.8–298.2) | – | – |